Gensci

Gensci company information, Employees & Contact Information

Explore related pages

Related company profiles:

Changchun GeneScience Pharmaceutical Co., Ltd. (GenSci), established in 1997, is a subsidiary of Changchun High-Tech Industries (Group) Co., Ltd. (stock code 000661). As a pioneering genetic engineering pharmaceutical company, GenSci stands as Asia's largest manufacturing base for recombinant human growth hormone and the world's exclusive provider of a comprehensive range of recombinant growth hormone products. Driven by the vision of becoming a global leader in pediatric and women's health, GenSci focuses on improving the health and well-being of children and women by offering innovative solutions to address unmet medical needs. The company has expanded its product portfolio beyond its core strengths to include adult endocrinology, dermatology, rheumatology & immunology and oncology with a commitment to addressing more healthcare challenges in diverse therapeutic areas. With nearly 30 years of unwavering dedication to the healthcare industry, GenSci has seamlessly integrated services, marketing, production, and R&D to serve patients worldwide.

Company Details

Employees
74
Founded
-
Address
8f, Block A, H88 Yuehong Plaza, 88 Hongcao Road, Xuhui District, Shanghai, Shanghai,china
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Shanghai
Looking for a particular Gensci employee's phone or email?

Gensci Questions

News

Design, Biological Characterization, and Discovery of Novel Cyclohexenyl Derivatives as Kinesin KIF18A Inhibitors for the Treatment of Ovarian Cancer | ACS Medicinal Chemistry Letters - ACS Publications

Design, Biological Characterization, and Discovery of Novel Cyclohexenyl Derivatives as Kinesin KIF18A Inhibitors for the Treatment of Ovarian Cancer | ACS Medicinal Chemistry Letters ACS Publications

Design, Biological Characterization, and Discovery of Capromorelin Derivatives as Oral Growth Hormone Secretagogue Receptor Type 1a Agonist for the Treatment of Growth Hormone Deficiency - ACS Publications

Design, Biological Characterization, and Discovery of Capromorelin Derivatives as Oral Growth Hormone Secretagogue Receptor Type 1a Agonist for the Treatment of Growth Hormone Deficiency ACS Publications

ALK and GenSci partner to expand the AIT market in China - The Manila Times

ALK and GenSci partner to expand the AIT market in China The Manila Times

Development of Highly Selective Aldosterone Synthase Inhibitors - ACS Publications

Development of Highly Selective Aldosterone Synthase Inhibitors ACS Publications

Design, Biological Characterization, and Discovery of Novel Cyclohexenyl Derivatives as Kinesin KIF18A Inhibitors for the Treatment of Ovarian Cancer - ACS Publications

Design, Biological Characterization, and Discovery of Novel Cyclohexenyl Derivatives as Kinesin KIF18A Inhibitors for the Treatment of Ovarian Cancer ACS Publications

Development of Highly Selective Aldosterone Synthase Inhibitors - ACS Publications

Development of Highly Selective Aldosterone Synthase Inhibitors ACS Publications

Top Gensci Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant